Skip to main content

View full-text article in PMC

. 2016 Sep 21;10(9):e0004920. doi: 10.1371/journal.pntd.0004920

Table 3. Rabies virus-neutralizing antibody titers >0.5 IU/mL and GMTs at each follow up visit.

	2 years after vaccination (2007)	3 years after vaccination (2008)	4 years after vaccination (2009)
Non-boosted population
Evaluable participants	488	400	364
RFFIT titers >0.5 IU/mL, n %: (95% CI)	413	352	312
RFFIT titers >0.5 IU/mL, n %: (95% CI)	84.6 (81.1–87.7)	88.0 (84.4–91.0)	85.7 (81.7–89.1)
GMT (95% CI)	1.10 (1.00–1.20)	1.11 (1.03–1.20)	1.00 (0.94–1.07)
Boosted population
Evaluable subjects	9	48	51
RFFIT titers >0.5 IU/mL, n %: (95% CI))	8	44	41
RFFIT titers >0.5 IU/mL, n %: (95% CI))	88.9 (51.8–99.7)	91.7 (80.0–97.7)	80.4 (66.9–90.2)
GMT (95% CI)	1.94 (0.73–5.14)	2.50 (1.82–3.41)	1.33 (1.03–1.70)